Inhibrx Biosciences Statistics
Total Valuation
INBX has a market cap or net worth of $979.40 million. The enterprise value is $962.19 million.
Important Dates
The next estimated earnings date is Wednesday, May 13, 2026, after market close.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
INBX has 14.61 million shares outstanding. The number of shares has increased by 3.36% in one year.
| Current Share Class | 14.61M |
| Shares Outstanding | 14.61M |
| Shares Change (YoY) | +3.36% |
| Shares Change (QoQ) | +0.36% |
| Owned by Insiders (%) | 18.85% |
| Owned by Institutions (%) | 60.42% |
| Float | 7.81M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 753.39 |
| Forward PS | n/a |
| PB Ratio | 122.29 |
| P/TBV Ratio | 122.53 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 740.15 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.93, with a Debt / Equity ratio of 13.39.
| Current Ratio | 3.93 |
| Quick Ratio | 3.68 |
| Debt / Equity | 13.39 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -11.07 |
Financial Efficiency
Return on equity (ROE) is -197.85% and return on invested capital (ROIC) is -65.77%.
| Return on Equity (ROE) | -197.85% |
| Return on Assets (ROA) | -51.58% |
| Return on Invested Capital (ROIC) | -65.77% |
| Return on Capital Employed (ROCE) | -119.83% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $11,818 |
| Profits Per Employee | -$1.27M |
| Employee Count | 110 |
| Asset Turnover | 0.01 |
| Inventory Turnover | 58.29 |
Taxes
In the past 12 months, INBX has paid $2,000 in taxes.
| Income Tax | 2,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +379.27% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +379.27% |
| 50-Day Moving Average | 73.95 |
| 200-Day Moving Average | 53.38 |
| Relative Strength Index (RSI) | 47.64 |
| Average Volume (20 Days) | 220,647 |
Short Selling Information
The latest short interest is 1.86 million, so 12.76% of the outstanding shares have been sold short.
| Short Interest | 1.86M |
| Short Previous Month | 1.73M |
| Short % of Shares Out | 12.76% |
| Short % of Float | 23.88% |
| Short Ratio (days to cover) | 11.22 |
Income Statement
In the last 12 months, INBX had revenue of $1.30 million and -$140.06 million in losses. Loss per share was -$9.04.
| Revenue | 1.30M |
| Gross Profit | -111.73M |
| Operating Income | -135.03M |
| Pretax Income | -140.05M |
| Net Income | -140.06M |
| EBITDA | -132.54M |
| EBIT | -135.03M |
| Loss Per Share | -$9.04 |
Full Income StatementBalance Sheet
The company has $124.22 million in cash and $107.01 million in debt, with a net cash position of $17.21 million or $1.18 per share.
| Cash & Cash Equivalents | 124.22M |
| Total Debt | 107.01M |
| Net Cash | 17.21M |
| Net Cash Per Share | $1.18 |
| Equity (Book Value) | 7.99M |
| Book Value Per Share | 0.55 |
| Working Capital | 99.03M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$129.79 million and capital expenditures -$31,000, giving a free cash flow of -$129.83 million.
| Operating Cash Flow | -129.79M |
| Capital Expenditures | -31,000 |
| Depreciation & Amortization | 2.48M |
| Net Borrowing | 99.97M |
| Free Cash Flow | -129.83M |
| FCF Per Share | -$8.89 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -10,386.54% |
| Pretax Margin | -10,773.31% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
INBX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.36% |
| Shareholder Yield | -3.36% |
| Earnings Yield | -14.30% |
| FCF Yield | -13.26% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | Hold |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
INBX has an Altman Z-Score of -2.68 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.68 |
| Piotroski F-Score | 3 |
